Spectacular suicide associated with mefloquine;Suicide spectaculaire lié à une prise de méfloquine

Presse Medicale

Volumn 35, Issue 5 I, 2006, Pages 789-792

  Jousset, Nathalie ^a,c   Guilleux, Michel ^a   De Gentile, Ludovic ^b   Le Bouil, Anne ^c   Turcant, Alain ^c   Rougé Maillart, Clotilde ^a  

^a Service de Médecine Légale   (France)

^b Service de Parasitologie et Mycologie

^c ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE PLUS PROGUANIL; MEFLOQUINE;

ACUTE PSYCHOSIS; ADULT; ARTICLE; AUTOPSY; CASE REPORT; HEAD INJURY; HUMAN; KNIFE CUT; MALE; SUICIDE;

EID: 33646721776     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74691-7     Document Type: Article

References (20)

1. Bernard J, Le Camus J, Sarrouy J. Encephalopathie toxique à la mefloquine. Presse Med. 1987; 16: 1654-55.
2. Stuiver PC, Ligthelm RJ, Goud TJ. Acute psychosis after mefloquine. Lancet. 1989; 2: 282.
3. Harinasuta T, Bunnag D, Wernsdorfer WH. A phase II clinical of mefloquine in patients with chloroquine-resistant falciparum malaria in Thailand. Bull World Health Organization. 1983; 61: 299-305.
4. World Health Organization. Prophylactic and therapeutic use of méfloquine. Weekly epidemiological record. 1989; 64: 247-8.
5. World health Organization. Review of central nervous system adverse events to the antimalarial drug mefloquine (1985- 1990). Unpublished document WHO/mal 91.1063. WHO, Geneva, 1991.
6. Barrett PJ, Emmins PD, Clarke PD, Bradley DJ Comparison of adverse events associated with use of mefloquine and combination of chloroquine and proguanil as antimalarial prophylaxis: postal and telephone survey of travellers. BMJ. 1996; 313: 525-8.
7. Hoebe C, De Munter J, Thijs C. Adverse effects and compliance with mefloquine or proguanil antimalaria chemoprophylaxis. Eur J Clin Pharm. 1997; 52: 269-75.
8. Bern JL, Kerr L, Stuerchler D. Mefloquine prophylaxis: an overview of spontaneous reports of severe psychiatric reactions and convulsions. J Trop Med Hyg. 1992; 95: 167-79.
9. Van Riemsdijk MM, Ditters JM, Sturkenboom MC, Tulen JH, Lighelm RJ, Overbosch D et al. Neuropsychiatric events during prophylactic use of mefloquine before travelling. Eur J Clin Pharmacol. 2002; 58: 441-5.
10. Rønn AM, Rønne-Rasmussen J, Gøtzsche PC, Bygbjerg IC. Neuropsychiatric manifestations after mefloquine therapy for Plasmodium falciparum malaria: comparing a retrospective and a prospective study. Trop Med Inter Health. 1998; 3: 83-8.
11. Meier CR, Wilcock K, Jick SS. The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf. 2004; 27: 203-13.
12. Van Riemsdijk MM, Sturkenboom MC, Ditters JM Tulen JH, Ligthelm RJ, Overbosch D et al. Low body mass index is associated with an increased risk of neuropsychiatric adverse events and concentration impairment in women on mefloquine. Br J Clin Pharmacol. 2004; 57: 506-12.
13. Potasman I, Beny A, Seligmann H. Neuropsychiatric problems in 2,500 long-term young travelers tropics. J Travel med. 2000; 7: 225-6.
14. Stürchler D, Handschin J, Kaiser D Kerr L, Mittelholzer ML, Reber R et al. Neuropsychiatric side effects of mefloquine. N Engl J Med. 1999; 14: 1752-3.
15. Clattenburg R N, Donnely CL. Case study: neuropsychiatric syptoms associated with the antimalarial agent mefloquine. J Am Child Adolesc Psychiatry. 1997; 36: 1606-8.
16. Ajana F, Fortier B, Martinet A, Rouveix B, Camus D. Prophylaxie par méfloquine et neurotoxicité. Sem Hôp Paris. 1990; 66: 918-9.
17. Clattenburg RN, Dommely CL. Case study: neuropsychiatric symptoms associated with the antimalarial agent mefloquine. J Am Child Adolesc Psychiatric. 1997; 36: 1606-8.
18. Lebain P, Juliard C, Davy JP, Dollfus S. Manifestations neuropsychiatriques lors des traitements préventifs par méfloquine. Encephale. 2000; 26: 67-70.
19. Schlagenhauf P. Mefloquine for malaria chemoprophylaxis 1992-1998. J Travel Med. 1999; 6: 122-33.
20. e conférence de consensus en thérapeutique anti-infectieuse de la Société de pathologie infectieuse de langue française (SPILF), 14 avril 1999. Consultable sur http://infectiologie.com